{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:11:16Z","timestamp":1775603476534,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2012ZX10002001, 2017ZX10105015"],"award-info":[{"award-number":["2012ZX10002001, 2017ZX10105015"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-7061-1","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T13:03:25Z","timestamp":1562591005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Self-motivated medical care-seeking behaviors and disease progression in a community-based cohort of chronic hepatitis B virus-infected patients in China"],"prefix":"10.1186","volume":"19","author":[{"given":"Hui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zundong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9029-0432","authenticated-orcid":false,"given":"Fuqiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"7061_CR1","volume-title":"Global hepatitis report 2017","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017."},{"issue":"33","key":"7061_CR2","doi-asserted-by":"publisher","first-page":"11595","DOI":"10.3748\/wjg.v20.i33.11595","volume":"20","author":"C Niederau","year":"2014","unstructured":"Niederau C. Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit. World J Gastroenterol. 2014;20(33):11595\u2013617.","journal-title":"World J Gastroenterol"},{"issue":"34","key":"7061_CR3","doi-asserted-by":"publisher","first-page":"12056","DOI":"10.3748\/wjg.v20.i34.12056","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Chen C, Li Z, Wu YH, Xiao XM. Individualized management of pregnant women with high hepatitis B virus DNA levels. World J Gastroenterol. 2014;20(34):12056\u201361.","journal-title":"World J Gastroenterol"},{"key":"7061_CR4","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Geneva, Switzerland: World Health Organization; 2016."},{"issue":"2","key":"7061_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","volume":"53","author":"GV Papatheodoridis","year":"2010","unstructured":"Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol. 2010;53(2):348\u201356.","journal-title":"J Hepatol"},{"key":"7061_CR6","doi-asserted-by":"crossref","unstructured":"Chen XX, Cheng JW, Huang A, Zhang X, Wang J, Fan J, et al. Onco Targets Ther 2017; 10: 5363\u20135375.","DOI":"10.2147\/OTT.S150281"},{"issue":"4","key":"7061_CR7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","volume":"62","author":"GV Papatheodoridis","year":"2015","unstructured":"Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol. 2015;62(4):956\u201367.","journal-title":"J Hepatol"},{"issue":"1","key":"7061_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1\u201398.","journal-title":"Hepatol Int"},{"issue":"5","key":"7061_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3201\/eid2305.161477","volume":"23","author":"F Cui","year":"2017","unstructured":"Cui F, Shen L, Li L, Wang H, Wang F, Bi S, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765\u201372.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"7061_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1086\/599332","volume":"200","author":"XF Liang","year":"2009","unstructured":"Liang XF, Bi SL, Yang WZ, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009;200(1):39\u201347.","journal-title":"J Infect Dis"},{"key":"7061_CR11","volume-title":"The National Report of hepatitis B Sero-survey in China","author":"Ministry of Health","year":"2010","unstructured":"Ministry of Health. Chinese Center for Disease Control and Prevention. In: The National Report of hepatitis B Sero-survey in China. Beijing: People\u2019s medical publishing house; 2010."},{"issue":"2","key":"7061_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"7061_CR13","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.27969","volume":"62","author":"C De Martel","year":"2015","unstructured":"De Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015;62(4):1190\u2013200.","journal-title":"Hepatology."},{"issue":"6","key":"7061_CR14","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099\u2013108.","journal-title":"Hepatology."},{"key":"7061_CR15","first-page":"20","volume":"6","author":"ZY Qu","year":"1986","unstructured":"Qu ZY. Epidemiological study on the distribution of surface antigen and surface antibody of hepatitis B virus in China. J Chin Microbiol Immunol. 1986;6(Suppl:20\u201340.","journal-title":"J Chin Microbiol Immunol"},{"issue":"8","key":"7061_CR16","first-page":"587","volume":"54","author":"SS Zhu","year":"2016","unstructured":"Zhu SS, Dong Y, Wang LM, Xu ZQ, Chen DW, Gan Y, et al. A retrospective study on the liver pathological characteristics and the effect of antiviral treatment for 1 to 7 years old children with heptitis B e antigen negative chronic hepatitis B. Chin J Pediatr. 2016;54(8):587\u201391.","journal-title":"Chin J Pediatr"},{"issue":"3","key":"7061_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clinre.2016.11.007","volume":"41","author":"ZQ Li","year":"2017","unstructured":"Li ZQ, Hu CL, Yu P, Gu XY, Zhang JJ, Li H, et al. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: incidence, long-term outcomes and predictive factors. Clin Res Hepatol Gastroenterol. 2017;41(3):311\u20138.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"25","key":"7061_CR18","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.3748\/wjg.v21.i25.7869","volume":"21","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zhang YG, Wang X, Qi WQ, Qin SY, Liu ZH, et al. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis. World J Gastroenterol. 2015;21(25):7869\u201376.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"7061_CR19","first-page":"120","volume":"21","author":"YZ Wu","year":"2007","unstructured":"Wu YZ, Zhao FL, Zhang CZ, Li MH, Xie Y. Factors related to the outcome of patients with chronic severe hepatitis B and effectiveness of antivirus therapy. Chin J Exp Clin Virol. 2007;21(2):120\u20132.","journal-title":"Chin J Exp Clin Virol"},{"key":"7061_CR20","volume-title":"Diagnostic criteria for viral hepatitis B (WS299\u20132008)","author":"Ministry of Health","year":"2008","unstructured":"Ministry of Health. Diagnostic criteria for viral hepatitis B (WS299\u20132008). 2008."},{"issue":"12","key":"7061_CR21","first-page":"888","volume":"23","author":"Chinese Society of Hepatology","year":"2015","unstructured":"Chinese Society of Hepatology. Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B, a 2015 update. Zhong Hua Gan Zang Bing Za Zhi. 2015;23(12):888\u2013905.","journal-title":"Zhong Hua Gan Zang Bing Za Zhi"},{"issue":"1","key":"7061_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00430-014-0380-z","volume":"204","author":"X Zheng","year":"2015","unstructured":"Zheng X, Wang J, Yang D. Antiviral therapy for chronic hepatitis B in China. Med Microbiol Immunol. 2015;204(1):115\u201320.","journal-title":"Med Microbiol Immunol"},{"issue":"4","key":"7061_CR23","first-page":"455","volume":"37","author":"H Zheng","year":"2016","unstructured":"Zheng H, Wang FZ, Zhang GM, Wu ZH, Miao N, Sun XJ, et al. Study on health-seeking behavior and influencing factors among Chinese hepatitis B surface antigen positive adults. Chin J Epidemiol. 2016;37(4):455\u20139.","journal-title":"Chin J Epidemiol"},{"issue":"6","key":"7061_CR24","first-page":"1031","volume":"24","author":"H Zhuang","year":"2016","unstructured":"Zhuang H. To improve the accessibility of hepatitis B treatment. J of Clin Hepatol. 2016;24(6):1031\u20132.","journal-title":"J of Clin Hepatol"},{"issue":"2","key":"7061_CR25","first-page":"117","volume":"35","author":"SZ Jiang","year":"2012","unstructured":"Jiang SZ, Lu FM, Zhuang H. The clinical significance of quantitative detection of HBV DNA in the chronic infected patients. Chin J Lab Med. 2012;35(2):117\u201321.","journal-title":"Chin J Lab Med"},{"issue":"1","key":"7061_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1142\/S0192415X76000032","volume":"122","author":"FM Lu","year":"2009","unstructured":"Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J. 2009;122(1):3\u20134.","journal-title":"Chin Med J"},{"issue":"1","key":"7061_CR27","doi-asserted-by":"publisher","first-page":"18334","DOI":"10.1038\/srep18334","volume":"5","author":"S Yang","year":"2015","unstructured":"Yang S, Yu C, Chen P, Deng M, Cao Q, Li Y, et al. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China. Sci Rep. 2015;5(1):18334\u201343.","journal-title":"Sci Rep"},{"issue":"5","key":"7061_CR28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/hep.21612","volume":"45","author":"CM Chu","year":"2007","unstructured":"Chu CM, Liaw YF. HBsAg sero-clearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology. 2007;45(5):1187\u201392.","journal-title":"Hepatology."},{"issue":"4","key":"7061_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.14218\/JCTH.2016.00019","volume":"5","author":"JL Hou","year":"2017","unstructured":"Hou JL, Wang GQ, Wang FS, Cheng J, Ren H, Zhuang H, et al. Guideline of prevention and treatment for chronic hepatitis B (2015 update). J Clin Transl Hepatol. 2017;5(4):297\u2013318.","journal-title":"J Clin Transl Hepatol"},{"issue":"29","key":"7061_CR30","first-page":"3103","volume":"14","author":"LP Zhang","year":"2008","unstructured":"Zhang LP, Zeng XZ, Zhao LJ, Yue JR. Study on impact factors of hepatitis B patients medical behaviors in Shenzhen. Chin J Mod Nurs. 2008;14(29):3103\u20134.","journal-title":"Chin J Mod Nurs"},{"issue":"4","key":"7061_CR31","first-page":"309","volume":"20","author":"H Zheng","year":"2014","unstructured":"Zheng H, Wang FZ, Zhuang GH, Zhang GM, Chen YS, Gong XH, et al. Quality of life among chronic hepatitis B virus infected people in their communities. Chin J Vaccin Immunization. 2014;20(4):309\u201313.","journal-title":"Chin J Vaccin Immunization"},{"issue":"17","key":"7061_CR32","first-page":"1570","volume":"28","author":"P Wang","year":"2013","unstructured":"Wang P, Li JW, Pan X, Wang LD, Wu GH. Investigation and analysis of hepatitis b disease cognition and discrimination. J Nurses Training. 2013;28(17):1570\u20132.","journal-title":"J Nurses Training"},{"issue":"5","key":"7061_CR33","first-page":"404","volume":"19","author":"FY Wang","year":"2010","unstructured":"Wang FY, Tang XD, Zhang YQ, Lin M, Liu G, Liu YL, et al. Investigation and analysis of factors for the quality of life in patients with chronic hepatitis B. Chin J Gastroenterol Hepatol. 2010;19(5):404\u20137.","journal-title":"Chin J Gastroenterol Hepatol"},{"issue":"2","key":"7061_CR34","first-page":"101","volume":"22","author":"H Zhuang","year":"2007","unstructured":"Zhuang H. Strengthen the antiviral therapy for chronic hepatitis B. Chin J Exp Clin Virol. 2007;22(2):101.","journal-title":"Chin J Exp Clin Virol"},{"key":"7061_CR35","volume-title":"WHO technical consultation on a comprehensive National Hepatitis Programme in China with a focus on viral hepatitis B and C treatment, Beijing, China, 21 February 2014: meeting report","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Regional Office for the Western Pacific. In: WHO technical consultation on a comprehensive National Hepatitis Programme in China with a focus on viral hepatitis B and C treatment, Beijing, China, 21 February 2014: meeting report. Manila: WHO Regional Office for the Western Pacific; 2014."},{"issue":"3","key":"7061_CR36","first-page":"254","volume":"3","author":"J Liu","year":"2013","unstructured":"Liu J. The investigation and analysis of knowledge of standard treatment and liver cancer among hepatitis B patients. Med Aesthetics Cosmetol. 2013;3(3):254\u20135.","journal-title":"Med Aesthetics Cosmetol"},{"issue":"3","key":"7061_CR37","first-page":"291","volume":"28","author":"XJ Pan","year":"2012","unstructured":"Pan XJ, Zheng M, Tu QF, Liu W. Knowledge of hepatis B among rural residents in Jiangxi province. Chin J Public Health. 2012;28(3):291\u20133.","journal-title":"Chin J Public Health"},{"key":"7061_CR38","unstructured":"http:\/\/www.nhc.gov.cn\/yaozs\/s3578\/201605\/168187d0028a44e0bbfb0be35d2d8c33.shtml\n                    \n                  . Accessed 22 Feb 2018."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7061-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-7061-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7061-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T23:14:25Z","timestamp":1594077265000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-7061-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["7061"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-7061-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics approval for this study was signed by the China CDC Ethical Review Committee (Ethics certificate:201339), and the study was conducted following the ethics regulations. Cohort participants were informed of the study purpose and their right to keep information confidential. Before the investigation, an informed consent form was signed by all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"901"}}